Skip to content

Public FDA record

Z-1394-2023: AQURE REF 933-599 Software Versions 2.5.2 2.5.3 2.5.4 2.6.0 2.6.1 The AQURE system is intended to let yo

Recall record Z-1394-2023 for Radiometer Medical ApS. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1394-2023
Company in FDA record
Radiometer Medical ApS
FDA classification date
Apr 17, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Due to potential software issue that may result in patient mix-up information.

Source facts

Action
On 03/08/2023, the firm sent an "Urgent: Medical Device Recall" letter via email and FedEx to customers informing them that there is a potential software issue that may result in patient information mix-up when connected to the LumiraDx device. This may potentially result in a patient with critically or life-threatening elevated levels of D-dimer or NT-pro-BNP being diagnosed with levels within the normal range. Customers are instructed to perform: 1) With immediate effect, cease using the LumiraDx devices if connected with an AQURE system with the affected software versions: 2.5.2, 2.5.3, 2.5.4 2.6.0 2.6.1 2) Within two weeks of receipt of this letter, complete and email a copy of the Recall Response Form and return it to a Radiometer Representative. A Radiometer Representative will contact and schedule a visit or remote session to: " If you use LumiraDx devices connected with AQURE, your AQURE system must be upgraded. Your local Radiometer representative will contact you when a solution is available. " If you do not use LumiraDx devices, your Radiometer representative will contact you and remove the LumiraDx driver from the AQURE system, hence preventing the usage of LumiraDx devices in context with your current AQURE system(s). For questions, contact Radiometer at 1-800-736-0600, Monday - Friday 9 am to 7 pm (EST).
Initiated
2023-03-08
Root cause
Software design
Distribution
Worldwide - U.S. Nationwide including in the states of AL, AR, AZ, CA, CO, CT, FL, GA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NM, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, and WV. The countries of Argentina, Australia, Austria, Bahrain, Brazil, Chile, China, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Iraq, Israel, Italy, Japan, Jordan, Kuwait, Lebanon, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Oman, Paraguay, Peru, Poland, Portugal, Qatar, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, Uruguay.
Recall number
Z-1394-2023
Recall status
Open, Classified
CDRH record ID
199211
FDA classified
2023-04-17
Recall event number
91917

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗